Blood Cancer
Showing 1–16 of 55 results
-
ADAKVEO (crizanlizumab-tmca) injection, for intravenous use. Initial U.S. Approval: 2019
Read more -
APHEXDA (motixafortide)
Read more -
Atriance (nelarabine) for injection
Read more -
BIMZELX (bimekizumab-bkzx) injection
Read more -
BLINCYTO (blinatumomab) for injection, for intravenous use. Initial U.S. Approval: 2014
Read more -
BOSULIF (bosutinib) tablets
Read more -
CABLIVI (caplacizumab-yhdp) for injection
Read more -
Columvi (glofitamab) for injection
Read more -
COTELLIC (cobimetinib) tablets. FDA-Approved
Read more -
DEFENCATH (taurolidine, heparin)
Read more -
EBGLYSS (lebrikizumab-lbkz) injection
Read more -
ELREXFIO (elranatamab-bcmm) injection
Read more -
EMPLICITI (elotuzumab) for injection
Read more -
EPKINLY (epcoritamab-bysp) injection
Read more -
ICLUSIG (ponatinib) tablets for oral use. Initial U.S. Approval: 2012
Read more -
Jakavi (ruxolitinib) Tablets
Read more
